[1]
Gillani, S.W. et al. 2021. Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials. Current Issues in Pharmacy and Medical Sciences. 34, 3 (Oct. 2021), 123–129. DOI:https://doi.org/10.2478/cipms-2021-0024.